DOI: 10.1016/j.tips.2007.06.005. The evasive nature of drug efficacy: implications for drug discovery

The evasive nature of drug efficacy: implications for drug discovery

10.1016/j.tips.2007.06.005

Crossref journal-article

Elsevier BV

Trends in Pharmacological Sciences (78)

Bibliography

Galandrin, S., Oligny-LongprÃ©, G., & Bouvier, M. (2007). The evasive nature of drug efficacy: implications for drug discovery. Trends in Pharmacological Sciences, 28(8), 423â430.

Authors 3

Ségolène Galandrin (first)
Geneviève Oligny-Longpré (additional)
Michel Bouvier (additional)

References 81 Referenced 308

{'year': '1937', 'series-title': "General Pharmacology: Heffter's Handbuch d. exp.Pharmacology", 'author': 'Clark', 'key': '10.1016/j.tips.2007.06.005_bib1'} / General Pharmacology: Heffter's Handbuch d. exp.Pharmacology by Clark (1937)
{'year': '1933', 'series-title': 'The Mode Of Action Of Drugs On Cells', 'author': 'Clark', 'key': '10.1016/j.tips.2007.06.005_bib2'} / The Mode Of Action Of Drugs On Cells by Clark (1933)
{'key': '10.1016/j.tips.2007.06.005_bib3', 'first-page': '379', 'article-title': 'A modification of receptor theory 1956', 'volume': '11', 'author': 'Stephenson', 'year': '1997', 'journal-title': 'Br. J. Pharmacol.'} / Br. J. Pharmacol. / A modification of receptor theory 1956 by Stephenson (1997)
10.1016/j.tips.2004.06.006 / Trends Pharmacol. Sci. / Historical review: a brief history and personal retrospective of seven-transmembrane receptors by Lefkowitz (2004)
{'key': '10.1016/j.tips.2007.06.005_bib5', 'first-page': '193', 'article-title': 'Affinity and intrinsic-activity in the theory of competitive inhibition. III. Homologous decamethonium-derivatives and succinyl-choline-esters', 'volume': '99', 'author': 'Ariens', 'year': '1954', 'journal-title': 'Arch. Int. Pharmacodyn. Ther.'} / Arch. Int. Pharmacodyn. Ther. / Affinity and intrinsic-activity in the theory of competitive inhibition. III. Homologous decamethonium-derivatives and succinyl-choline-esters by Ariens (1954)
{'key': '10.1016/j.tips.2007.06.005_bib6', 'first-page': '490', 'article-title': 'Inverse agonist activity of beta-adrenergic antagonists', 'volume': '45', 'author': 'Chidiac', 'year': '1994', 'journal-title': 'Mol. Pharmacol.'} / Mol. Pharmacol. / Inverse agonist activity of beta-adrenergic antagonists by Chidiac (1994)
{'key': '10.1016/j.tips.2007.06.005_bib7', 'first-page': '390', 'article-title': 'Negative antagonists promote an inactive conformation of the beta 2-adrenergic receptor', 'volume': '45', 'author': 'Samama', 'year': '1994', 'journal-title': 'Mol. Pharmacol.'} / Mol. Pharmacol. / Negative antagonists promote an inactive conformation of the beta 2-adrenergic receptor by Samama (1994)
10.1016/j.tips.2005.12.007 / Trends Pharmacol. Sci. / Recent developments in constitutive receptor activity and inverse agonism, and their potential for GPCR drug discovery by Bond (2006)
10.1124/mol.64.6.1271 / Mol. Pharmacol. / Constitutive activity and inverse agonists of G protein-coupled receptors: a current perspective by Milligan (2003)
10.1016/S0163-7258(03)00051-2 / Pharmacol. Ther. / Biochemical and pharmacological control of the multiplicity of coupling at G-protein-coupled receptors by Hermans (2003)
10.1073/pnas.93.1.116 / Proc. Natl. Acad. Sci. U. S. A. / The human thyrotropin receptor: a heptahelical receptor capable of stimulating members of all four G protein families by Laugwitz (1996)
10.1016/S0898-6568(01)00239-X / Cell. Signal. / G protein-coupled receptor interacting proteins: emerging roles in localization and signal transduction by Brady (2002)
10.1016/j.pharmthera.2004.06.004 / Pharmacol. Ther. / GPCR interacting proteins (GIP) by Bockaert (2004)
10.1146/annurev.physiol.69.022405.154749 / Annu. Rev. Physiol. / beta-Arrestins and Cell Signaling by Dewire (2007)
10.1016/S0022-3565(24)39104-9 / J. Pharmacol. Exp. Ther. / Agonist-directed trafficking of porcine alpha(2A)-adrenergic receptor signaling in Chinese hamster ovary cells: l-isoproterenol selectively activates G(s) by Brink (2000)
10.1124/mol.54.1.94 / Mol. Pharmacol. / Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: evidence for agonist-directed trafficking of receptor stimulus by Berg (1998)
10.1038/365170a0 / Nature / Differential signal transduction by five splice variants of the PACAP receptor by Spengler (1993)
10.1124/mol.66.1.97 / Mol. Pharmacol. / Functional selectivity of D2 receptor ligands in a Chinese hamster ovary hD2L cell line: evidence for induction of ligand-specific receptor states by Gay (2004)
10.1124/jpet.105.089474 / J. Pharmacol. Exp. Ther. / Agonist-directed trafficking of response by endocannabinoids acting at CB2 receptors by Shoemaker (2005)
10.1124/jpet.102.042184 / J. Pharmacol. Exp. Ther. / Serotonin 5-hydroxytryptamine 2A receptor-coupled phospholipase C and phospholipase A2 signaling pathways have different receptor reserves by Kurrasch-Orbaugh (2003)
10.1074/jbc.M414090200 / J. Biol. Chem. / Functional selectivity of G protein signaling by agonist peptides and thrombin for the protease-activated receptor-1 by McLaughlin (2005)
10.1038/sj.bjp.0702329 / Br. J. Pharmacol. / Signalling by CXC-chemokine receptors 1 and 2 expressed in CHO cells: a comparison of calcium mobilization, inhibition of adenylyl cyclase and stimulation of GTPgammaS binding induced by IL-8 and GROalpha by Hall (1999)
10.1124/jpet.104.070086 / J. Pharmacol. Exp. Ther. / Ligand-directed functional heterogeneity of histamine H1 receptors: novel dual-function ligands selectively activate and block H1-mediated phospholipase C and adenylyl cyclase signaling by Moniri (2004)
10.1124/jpet.104.078865 / J. Pharmacol. Exp. Ther. / G protein-dependent pharmacology of histamine H3 receptor ligands: evidence for heterogeneous active state receptor conformations by Krueger (2005)
10.1074/jbc.271.22.12826 / J. Biol. Chem. / Chimeric mutagenesis of putative G-protein coupling domains of the alpha2A-adrenergic receptor. Localization of two redundant and fully competent gi coupling domains by Eason (1996)
10.1016/S0165-6147(03)00167-6 / Trends Pharmacol. Sci. / Ligand-selective receptor conformations revisited: the promise and the problem by Kenakin (2003)
10.1016/S0165-6147(00)89032-X / Trends Pharmacol. Sci. / Agonist-receptor efficacy. II. Agonist trafficking of receptor signals by Kenakin (1995)
10.1074/jbc.273.5.3097 / J. Biol. Chem. / [D-Arg1,D-Phe5,D-Trp7,9,Leu11]Substance P acts as a biased agonist toward neuropeptide and chemokine receptors by Jarpe (1998)
10.1124/jpet.106.104463 / J. Pharmacol. Exp. Ther. / Functional selectivity and classical concepts of quantitative pharmacology by Urban (2007)
10.1073/pnas.1936664100 / Proc. Natl. Acad. Sci. U. S. A. / Beta-arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors by Azzi (2003)
10.1073/pnas.1932276100 / Proc. Natl. Acad. Sci. U. S. A. / Protean agonism at histamine H3 receptors in vitro and in vivo by Gbahou (2003)
10.1124/mol.64.6.1357 / Mol. Pharmacol. / Agonist and inverse agonist actions of beta-blockers at the human beta 2-adrenoceptor provide evidence for agonist-directed signaling by Baker (2003)
10.1074/jbc.M411695200 / J. Biol. Chem. / Internalization and Src activity regulate the time course of ERK activation by delta opioid receptor ligands by Audet (2005)
10.1111/j.1471-4159.2005.03161.x / J. Neurochem. / Characterization of serotonin 5-HT2C receptor signaling to extracellular signal-regulated kinases 1 and 2 by Werry (2005)
10.1124/mol.106.026716 / Mol. Pharmacol. / Distinct signaling profiles of beta1 and beta2 adrenergic receptor ligands toward adenylyl cyclase and mitogen-activated protein kinase reveals the pluridimensionality of efficacy by Galandrin (2006)
10.1074/jbc.270.47.28268 / J. Biol. Chem. / Fluorescent labeling of purified beta 2 adrenergic receptor. Evidence for ligand-specific conformational changes by Gether (1995)
10.1074/jbc.C100162200 / J. Biol. Chem. / Functionally different agonists induce distinct conformations in the G protein coupling domain of the beta 2 adrenergic receptor by Ghanouni (2001)
10.1038/nchembio705 / Nat. Chem. Biol. / Molecular basis of inverse agonism in a G protein-coupled receptor by Vilardaga (2005)
10.1038/nmeth742 / Nat. Methods / A FlAsH-based FRET approach to determine G protein-coupled receptor activation in living cells by Hoffmann (2005)
10.1038/nmeth743 / Nat. Methods / Real-time monitoring of receptor and G-protein interactions in living cells by Gales (2005)
10.1038/nsmb1134 / Nat. Struct. Mol. Biol. / Probing the activation-promoted structural rearrangements in preassembled receptor-G protein complexes by Gales (2006)
10.1042/0264-6021:3420071 / Biochem. J. / Differential G-protein activation by alkaloid and peptide opioid agonists in the human neuroblastoma cell line SK-N-BE by Allouche (1999)
10.1124/mol.104.003558 / Mol. Pharmacol. / Chemically distinct ligands promote differential CB1 cannabinoid receptor-Gi protein interactions by Mukhopadhyay (2005)
10.1124/mol.62.3.578 / Mol. Pharmacol. / Differential activation of Gq/11 and Gi(3) proteins at 5-hydroxytryptamine(2C) receptors revealed by antibody capture assays: influence of receptor reserve and relationship to agonist-directed trafficking by Cussac (2002)
{'key': '10.1016/j.tips.2007.06.005_bib45', 'first-page': '775', 'article-title': 'Functional coupling of the human dopamine D2 receptor with G alpha i1, G alpha i2', 'volume': '138', 'author': 'Gazi', 'year': '2003', 'journal-title': 'G alpha i3 and G alpha o G proteins: evidence for agonist regulation of G protein selectivity. Br. J. Pharmacol.'} / G alpha i3 and G alpha o G proteins: evidence for agonist regulation of G protein selectivity. Br. J. Pharmacol. / Functional coupling of the human dopamine D2 receptor with G alpha i1, G alpha i2 by Gazi (2003)
10.1046/j.1471-4159.2000.0751190.x / J. Neurochem. / Coupling efficacy and selectivity of the human mu-opioid receptor expressed as receptor-Galpha fusion proteins in Escherichia coli by Stanasila (2000)
10.1124/jpet.105.096818 / J. Pharmacol. Exp. Ther. / Comparison of the relative efficacy and potency of mu-opioid agonists to activate Galpha(i/o) proteins containing a pertussis toxin-insensitive mutation by Clark (2006)
10.1073/pnas.0509588102 / Proc. Natl. Acad. Sci. U. S. A. / The cannabinoid agonist WIN55,212-2 increases intracellular calcium via CB1 receptor coupling to Gq/11 G proteins by Lauckner (2005)
10.1074/jbc.M008644200 / J. Biol. Chem. / Agonist regulation of D(2) dopamine receptor/G protein interaction. Evidence for agonist selection of G protein subtype by Cordeaux (2001)
10.1124/mol.58.6.1230 / Mol. Pharmacol. / The use of stimulus-biased assay systems to detect agonist-specific receptor active states: implications for the trafficking of receptor stimulus by agonists by Watson (2000)
10.1074/jbc.M009772200 / J. Biol. Chem. / Bombesin and substance P analogues differentially regulate G-protein coupling to the bombesin receptor. Direct evidence for biased agonism by MacKinnon (2001)
10.1124/mol.58.5.954 / Mol. Pharmacol. / Molecular analysis of beta(2)-adrenoceptor coupling to G(s)-, G(i)-, and G(q)-proteins by Wenzel-Seifert (2000)
10.1073/pnas.1834556100 / Proc. Natl. Acad. Sci. U. S. A. / Independent beta-arrestin 2 and G protein-mediated pathways for angiotensin II activation of extracellular signal-regulated kinases 1 and 2 by Wei (2003)
10.1016/j.cellsig.2006.05.020 / Cell. Signal. / The V2 vasopressin receptor stimulates ERK1/2 activity independently of heterotrimeric G protein signalling by Charest (2007)
10.1074/jbc.M513380200 / J. Biol. Chem. / Distinct beta-arrestin- and G protein-dependent pathways for parathyroid hormone receptor-stimulated ERK1/2 activation by Gesty-Palmer (2006)
10.1038/nrd1875 / Nat. Rev. Drug Discov. / New concepts in drug discovery: collateral efficacy and permissive antagonism by Kenakin (2005)
10.1074/jbc.275.4.2893 / J. Biol. Chem. / Agonist-induced phosphorylation of the angiotensin II (AT(1A)) receptor requires generation of a conformation that is distinct from the inositol phosphate-signaling state by Thomas (2000)
10.1124/jpet.302.3.957 / J. Pharmacol. Exp. Ther. / Rapid desensitization of the serotonin(2C) receptor system: effector pathway and agonist dependence by Stout (2002)
10.1074/jbc.272.2.782 / J. Biol. Chem. / Differential opioid agonist regulation of the mouse mu opioid receptor by Blake (1997)
10.1046/j.1471-4159.1998.71010231.x / J. Neurochem. / Distinct differences between morphine- and [D-Ala2,N-MePhe4,Gly-ol5]-enkephalin-mu-opioid receptor complexes demonstrated by cyclic AMP-dependent protein kinase phosphorylation by Chakrabarti (1998)
10.1074/jbc.M402125200 / J. Biol. Chem. / Differential desensitization, receptor phosphorylation, beta-arrestin recruitment, and ERK1/2 activation by the two endogenous ligands for the CC chemokine receptor 7 by Kohout (2004)
10.1054/npep.2000.0840 / Neuropeptides / The N-terminal domain of substance P is required for complete homologous desensitization but not phosphorylation of the rat neurokinin-1 receptor by Vigna (2001)
10.1073/pnas.95.17.9914 / Proc. Natl. Acad. Sci. U. S. A. / Morphine-activated opioid receptors elude desensitization by beta-arrestin by Whistler (1998)
10.1124/jpet.106.109512 / J. Pharmacol. Exp. Ther. / Functional selectivity of NK1 receptor signaling: peptide agonists can preferentially produce receptor activation or desensitization by Simmons (2006)
10.1016/S0361-9230(01)00623-2 / Brain Res. Bull. / Paradoxical trafficking and regulation of 5-HT(2A) receptors by agonists and antagonists by Gray (2001)
10.1016/S0026-895X(24)13474-8 / Mol. Pharmacol. / Antagonist-stimulated internalization of the G protein-coupled cholecystokinin receptor by Roettger (1997)
10.1210/endo.139.7.6105 / Endocrinology / The endothelin subtype A receptor undergoes agonist- and antagonist-mediated internalization in the absence of signaling by Bhowmick (1998)
10.1074/jbc.M306019200 / J. Biol. Chem. / Activation-independent parathyroid hormone receptor internalization is regulated by NHERF1 (EBP50) by Sneddon (2003)
10.1038/sj.bjp.0705306 / Br. J. Pharmacol. / Agonist- and antagonist-induced sequestration/internalization of neuropeptide Y Y1 receptors in HEK293 cells by Pheng (2003)
10.4049/jimmunol.163.6.3037 / J. Immunol. / Characterization of RANTES- and aminooxypentane-RANTES-triggered desensitization signals reveals differences in recruitment of the G protein-coupled receptor complex by Vila-Coro (1999)
10.1124/jpet.105.083337 / J. Pharmacol. Exp. Ther. / Functional selectivity of melanocortin 4 receptor peptide and nonpeptide agonists: evidence for ligand-specific conformational states by Nickolls (2005)
10.1074/jbc.M605982200 / J. Biol. Chem. / The natural inverse agonist agouti-related protein induces arrestin-mediated endocytosis of melanocortin-3 and -4 receptors by Breit (2006)
10.1146/annurev.pharmtox.42.091401.113012 / Annu. Rev. Pharmacol. Toxicol. / Drug efficacy at G protein-coupled receptors by Kenakin (2002)
10.1038/sj.onc.1204184 / Oncogene / New mechanisms in heptahelical receptor signaling to mitogen activated protein kinase cascades by Pierce (2001)
10.1016/S0896-6273(01)80032-5 / Neuron / Functional dissociation of mu opioid receptor signaling and endocytosis: implications for the biology of opiate tolerance and addiction by Whistler (1999)
10.1124/jpet.105.090308 / J. Pharmacol. Exp. Ther. / Allosteric potentiators of metabotropic glutamate receptor subtype 5 have differential effects on different signaling pathways in cortical astrocytes by Zhang (2005)
10.1002/cyto.a.20266 / Cytometry A / Multiplexed and microparticle-based analyses: quantitative tools for the large-scale analysis of biological systems by Nolan (2006)
10.1016/j.tips.2004.10.009 / Trends Pharmacol. Sci. / Techniques: GPCR assembly, pharmacology and screening by flow cytometry by Waller (2004)
10.1089/adt.2004.2.431 / Assay Drug Dev. Technol. / Rapid structure-activity and selectivity analysis of kinase inhibitors by BioMAP analysis in complex human primary cell-based models by Kunkel (2004)
10.1096/fj.04-1538fje / FASEB J. / An integrative biology approach for analysis of drug action in models of human vascular inflammation by Kunkel (2004)
10.1016/S0076-6879(02)43134-5 / Methods Enzymol. / Use of fluorescence spectroscopy to study conformational changes in the beta 2-adrenoceptor by Kobilka (2002)

Dates

Type	When
Created	18 years, 1 month ago (July 20, 2007, 9:38 a.m.)
Deposited	7 months, 1 week ago (Jan. 19, 2025, 3:18 p.m.)
Indexed	4 days, 1 hour ago (Aug. 29, 2025, 6:09 a.m.)
Issued	18 years, 1 month ago (Aug. 1, 2007)
Published	18 years, 1 month ago (Aug. 1, 2007)
Published Print	18 years, 1 month ago (Aug. 1, 2007)

Funders 0

None

BibTeX

@article{Galandrin_2007, title={The evasive nature of drug efficacy: implications for drug discovery}, volume={28}, ISSN={0165-6147}, url={http://dx.doi.org/10.1016/j.tips.2007.06.005}, DOI={10.1016/j.tips.2007.06.005}, number={8}, journal={Trends in Pharmacological Sciences}, publisher={Elsevier BV}, author={Galandrin, Ségolène and Oligny-Longpré, Geneviève and Bouvier, Michel}, year={2007}, month=aug, pages={423–430} }

JSON

{
  "indexed": {
    "date-parts": [
      [
        2025,
        8,
        29
      ]
    ],
    "date-time": "2025-08-29T10:09:09Z",
    "timestamp": 1756462149125,
    "version": "3.33.0"
  },
  "reference-count": 81,
  "publisher": "Elsevier BV",
  "issue": "8",
  "license": [
    {
      "start": {
        "date-parts": [
          [
            2007,
            8,
            1
          ]
        ],
        "date-time": "2007-08-01T00:00:00Z",
        "timestamp": 1185926400000
      },
      "content-version": "tdm",
      "delay-in-days": 0,
      "URL": "https://www.elsevier.com/tdm/userlicense/1.0/"
    }
  ],
  "content-domain": {
    "domain": [],
    "crossmark-restriction": false
  },
  "published-print": {
    "date-parts": [
      [
        2007,
        8
      ]
    ]
  },
  "DOI": "10.1016/j.tips.2007.06.005",
  "type": "journal-article",
  "created": {
    "date-parts": [
      [
        2007,
        7,
        20
      ]
    ],
    "date-time": "2007-07-20T13:38:22Z",
    "timestamp": 1184938702000
  },
  "page": "423-430",
  "source": "Crossref",
  "is-referenced-by-count": 308,
  "title": "The evasive nature of drug efficacy: implications for drug discovery",
  "prefix": "10.1016",
  "volume": "28",
  "author": [
    {
      "given": "S\u00e9gol\u00e8ne",
      "family": "Galandrin",
      "sequence": "first",
      "affiliation": []
    },
    {
      "given": "Genevi\u00e8ve",
      "family": "Oligny-Longpr\u00e9",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Michel",
      "family": "Bouvier",
      "sequence": "additional",
      "affiliation": []
    }
  ],
  "member": "78",
  "reference": [
    {
      "year": "1937",
      "series-title": "General Pharmacology: Heffter's Handbuch d. exp.Pharmacology",
      "author": "Clark",
      "key": "10.1016/j.tips.2007.06.005_bib1"
    },
    {
      "year": "1933",
      "series-title": "The Mode Of Action Of Drugs On Cells",
      "author": "Clark",
      "key": "10.1016/j.tips.2007.06.005_bib2"
    },
    {
      "key": "10.1016/j.tips.2007.06.005_bib3",
      "first-page": "379",
      "article-title": "A modification of receptor theory 1956",
      "volume": "11",
      "author": "Stephenson",
      "year": "1997",
      "journal-title": "Br. J. Pharmacol."
    },
    {
      "key": "10.1016/j.tips.2007.06.005_bib4",
      "doi-asserted-by": "crossref",
      "first-page": "413",
      "DOI": "10.1016/j.tips.2004.06.006",
      "article-title": "Historical review: a brief history and personal retrospective of seven-transmembrane receptors",
      "volume": "25",
      "author": "Lefkowitz",
      "year": "2004",
      "journal-title": "Trends Pharmacol. Sci."
    },
    {
      "key": "10.1016/j.tips.2007.06.005_bib5",
      "first-page": "193",
      "article-title": "Affinity and intrinsic-activity in the theory of competitive inhibition. III. Homologous decamethonium-derivatives and succinyl-choline-esters",
      "volume": "99",
      "author": "Ariens",
      "year": "1954",
      "journal-title": "Arch. Int. Pharmacodyn. Ther."
    },
    {
      "key": "10.1016/j.tips.2007.06.005_bib6",
      "first-page": "490",
      "article-title": "Inverse agonist activity of beta-adrenergic antagonists",
      "volume": "45",
      "author": "Chidiac",
      "year": "1994",
      "journal-title": "Mol. Pharmacol."
    },
    {
      "key": "10.1016/j.tips.2007.06.005_bib7",
      "first-page": "390",
      "article-title": "Negative antagonists promote an inactive conformation of the beta 2-adrenergic receptor",
      "volume": "45",
      "author": "Samama",
      "year": "1994",
      "journal-title": "Mol. Pharmacol."
    },
    {
      "key": "10.1016/j.tips.2007.06.005_bib8",
      "doi-asserted-by": "crossref",
      "first-page": "92",
      "DOI": "10.1016/j.tips.2005.12.007",
      "article-title": "Recent developments in constitutive receptor activity and inverse agonism, and their potential for GPCR drug discovery",
      "volume": "27",
      "author": "Bond",
      "year": "2006",
      "journal-title": "Trends Pharmacol. Sci."
    },
    {
      "key": "10.1016/j.tips.2007.06.005_bib9",
      "doi-asserted-by": "crossref",
      "first-page": "1271",
      "DOI": "10.1124/mol.64.6.1271",
      "article-title": "Constitutive activity and inverse agonists of G protein-coupled receptors: a current perspective",
      "volume": "64",
      "author": "Milligan",
      "year": "2003",
      "journal-title": "Mol. Pharmacol."
    },
    {
      "key": "10.1016/j.tips.2007.06.005_bib10",
      "doi-asserted-by": "crossref",
      "first-page": "25",
      "DOI": "10.1016/S0163-7258(03)00051-2",
      "article-title": "Biochemical and pharmacological control of the multiplicity of coupling at G-protein-coupled receptors",
      "volume": "99",
      "author": "Hermans",
      "year": "2003",
      "journal-title": "Pharmacol. Ther."
    },
    {
      "key": "10.1016/j.tips.2007.06.005_bib11",
      "doi-asserted-by": "crossref",
      "first-page": "116",
      "DOI": "10.1073/pnas.93.1.116",
      "article-title": "The human thyrotropin receptor: a heptahelical receptor capable of stimulating members of all four G protein families",
      "volume": "93",
      "author": "Laugwitz",
      "year": "1996",
      "journal-title": "Proc. Natl. Acad. Sci. U. S. A."
    },
    {
      "key": "10.1016/j.tips.2007.06.005_bib12",
      "doi-asserted-by": "crossref",
      "first-page": "297",
      "DOI": "10.1016/S0898-6568(01)00239-X",
      "article-title": "G protein-coupled receptor interacting proteins: emerging roles in localization and signal transduction",
      "volume": "14",
      "author": "Brady",
      "year": "2002",
      "journal-title": "Cell. Signal."
    },
    {
      "key": "10.1016/j.tips.2007.06.005_bib13",
      "doi-asserted-by": "crossref",
      "first-page": "203",
      "DOI": "10.1016/j.pharmthera.2004.06.004",
      "article-title": "GPCR interacting proteins (GIP)",
      "volume": "103",
      "author": "Bockaert",
      "year": "2004",
      "journal-title": "Pharmacol. Ther."
    },
    {
      "key": "10.1016/j.tips.2007.06.005_bib14",
      "doi-asserted-by": "crossref",
      "first-page": "483",
      "DOI": "10.1146/annurev.physiol.69.022405.154749",
      "article-title": "beta-Arrestins and Cell Signaling",
      "volume": "69",
      "author": "Dewire",
      "year": "2007",
      "journal-title": "Annu. Rev. Physiol."
    },
    {
      "key": "10.1016/j.tips.2007.06.005_bib15",
      "doi-asserted-by": "crossref",
      "first-page": "539",
      "DOI": "10.1016/S0022-3565(24)39104-9",
      "article-title": "Agonist-directed trafficking of porcine alpha(2A)-adrenergic receptor signaling in Chinese hamster ovary cells: l-isoproterenol selectively activates G(s)",
      "volume": "294",
      "author": "Brink",
      "year": "2000",
      "journal-title": "J. Pharmacol. Exp. Ther."
    },
    {
      "key": "10.1016/j.tips.2007.06.005_bib16",
      "doi-asserted-by": "crossref",
      "first-page": "94",
      "DOI": "10.1124/mol.54.1.94",
      "article-title": "Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: evidence for agonist-directed trafficking of receptor stimulus",
      "volume": "54",
      "author": "Berg",
      "year": "1998",
      "journal-title": "Mol. Pharmacol."
    },
    {
      "key": "10.1016/j.tips.2007.06.005_bib17",
      "doi-asserted-by": "crossref",
      "first-page": "170",
      "DOI": "10.1038/365170a0",
      "article-title": "Differential signal transduction by five splice variants of the PACAP receptor",
      "volume": "365",
      "author": "Spengler",
      "year": "1993",
      "journal-title": "Nature"
    },
    {
      "key": "10.1016/j.tips.2007.06.005_bib18",
      "doi-asserted-by": "crossref",
      "first-page": "97",
      "DOI": "10.1124/mol.66.1.97",
      "article-title": "Functional selectivity of D2 receptor ligands in a Chinese hamster ovary hD2L cell line: evidence for induction of ligand-specific receptor states",
      "volume": "66",
      "author": "Gay",
      "year": "2004",
      "journal-title": "Mol. Pharmacol."
    },
    {
      "key": "10.1016/j.tips.2007.06.005_bib19",
      "doi-asserted-by": "crossref",
      "first-page": "828",
      "DOI": "10.1124/jpet.105.089474",
      "article-title": "Agonist-directed trafficking of response by endocannabinoids acting at CB2 receptors",
      "volume": "315",
      "author": "Shoemaker",
      "year": "2005",
      "journal-title": "J. Pharmacol. Exp. Ther."
    },
    {
      "key": "10.1016/j.tips.2007.06.005_bib20",
      "doi-asserted-by": "crossref",
      "first-page": "229",
      "DOI": "10.1124/jpet.102.042184",
      "article-title": "Serotonin 5-hydroxytryptamine 2A receptor-coupled phospholipase C and phospholipase A2 signaling pathways have different receptor reserves",
      "volume": "304",
      "author": "Kurrasch-Orbaugh",
      "year": "2003",
      "journal-title": "J. Pharmacol. Exp. Ther."
    },
    {
      "key": "10.1016/j.tips.2007.06.005_bib21",
      "doi-asserted-by": "crossref",
      "first-page": "25048",
      "DOI": "10.1074/jbc.M414090200",
      "article-title": "Functional selectivity of G protein signaling by agonist peptides and thrombin for the protease-activated receptor-1",
      "volume": "280",
      "author": "McLaughlin",
      "year": "2005",
      "journal-title": "J. Biol. Chem."
    },
    {
      "key": "10.1016/j.tips.2007.06.005_bib22",
      "doi-asserted-by": "crossref",
      "first-page": "810",
      "DOI": "10.1038/sj.bjp.0702329",
      "article-title": "Signalling by CXC-chemokine receptors 1 and 2 expressed in CHO cells: a comparison of calcium mobilization, inhibition of adenylyl cyclase and stimulation of GTPgammaS binding induced by IL-8 and GROalpha",
      "volume": "126",
      "author": "Hall",
      "year": "1999",
      "journal-title": "Br. J. Pharmacol."
    },
    {
      "key": "10.1016/j.tips.2007.06.005_bib23",
      "doi-asserted-by": "crossref",
      "first-page": "274",
      "DOI": "10.1124/jpet.104.070086",
      "article-title": "Ligand-directed functional heterogeneity of histamine H1 receptors: novel dual-function ligands selectively activate and block H1-mediated phospholipase C and adenylyl cyclase signaling",
      "volume": "311",
      "author": "Moniri",
      "year": "2004",
      "journal-title": "J. Pharmacol. Exp. Ther."
    },
    {
      "key": "10.1016/j.tips.2007.06.005_bib24",
      "doi-asserted-by": "crossref",
      "first-page": "271",
      "DOI": "10.1124/jpet.104.078865",
      "article-title": "G protein-dependent pharmacology of histamine H3 receptor ligands: evidence for heterogeneous active state receptor conformations",
      "volume": "314",
      "author": "Krueger",
      "year": "2005",
      "journal-title": "J. Pharmacol. Exp. Ther."
    },
    {
      "key": "10.1016/j.tips.2007.06.005_bib25",
      "doi-asserted-by": "crossref",
      "first-page": "12826",
      "DOI": "10.1074/jbc.271.22.12826",
      "article-title": "Chimeric mutagenesis of putative G-protein coupling domains of the alpha2A-adrenergic receptor. Localization of two redundant and fully competent gi coupling domains",
      "volume": "271",
      "author": "Eason",
      "year": "1996",
      "journal-title": "J. Biol. Chem."
    },
    {
      "key": "10.1016/j.tips.2007.06.005_bib26",
      "doi-asserted-by": "crossref",
      "first-page": "346",
      "DOI": "10.1016/S0165-6147(03)00167-6",
      "article-title": "Ligand-selective receptor conformations revisited: the promise and the problem",
      "volume": "24",
      "author": "Kenakin",
      "year": "2003",
      "journal-title": "Trends Pharmacol. Sci."
    },
    {
      "key": "10.1016/j.tips.2007.06.005_bib27",
      "doi-asserted-by": "crossref",
      "first-page": "232",
      "DOI": "10.1016/S0165-6147(00)89032-X",
      "article-title": "Agonist-receptor efficacy. II. Agonist trafficking of receptor signals",
      "volume": "16",
      "author": "Kenakin",
      "year": "1995",
      "journal-title": "Trends Pharmacol. Sci."
    },
    {
      "key": "10.1016/j.tips.2007.06.005_bib28",
      "doi-asserted-by": "crossref",
      "first-page": "3097",
      "DOI": "10.1074/jbc.273.5.3097",
      "article-title": "[D-Arg1,D-Phe5,D-Trp7,9,Leu11]Substance P acts as a biased agonist toward neuropeptide and chemokine receptors",
      "volume": "273",
      "author": "Jarpe",
      "year": "1998",
      "journal-title": "J. Biol. Chem."
    },
    {
      "key": "10.1016/j.tips.2007.06.005_bib29",
      "doi-asserted-by": "crossref",
      "first-page": "1",
      "DOI": "10.1124/jpet.106.104463",
      "article-title": "Functional selectivity and classical concepts of quantitative pharmacology",
      "volume": "320",
      "author": "Urban",
      "year": "2007",
      "journal-title": "J. Pharmacol. Exp. Ther."
    },
    {
      "key": "10.1016/j.tips.2007.06.005_bib30",
      "doi-asserted-by": "crossref",
      "first-page": "11406",
      "DOI": "10.1073/pnas.1936664100",
      "article-title": "Beta-arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors",
      "volume": "100",
      "author": "Azzi",
      "year": "2003",
      "journal-title": "Proc. Natl. Acad. Sci. U. S. A."
    },
    {
      "key": "10.1016/j.tips.2007.06.005_bib31",
      "doi-asserted-by": "crossref",
      "first-page": "11086",
      "DOI": "10.1073/pnas.1932276100",
      "article-title": "Protean agonism at histamine H3 receptors in vitro and in vivo",
      "volume": "100",
      "author": "Gbahou",
      "year": "2003",
      "journal-title": "Proc. Natl. Acad. Sci. U. S. A."
    },
    {
      "key": "10.1016/j.tips.2007.06.005_bib32",
      "doi-asserted-by": "crossref",
      "first-page": "1357",
      "DOI": "10.1124/mol.64.6.1357",
      "article-title": "Agonist and inverse agonist actions of beta-blockers at the human beta 2-adrenoceptor provide evidence for agonist-directed signaling",
      "volume": "64",
      "author": "Baker",
      "year": "2003",
      "journal-title": "Mol. Pharmacol."
    },
    {
      "key": "10.1016/j.tips.2007.06.005_bib33",
      "doi-asserted-by": "crossref",
      "first-page": "7808",
      "DOI": "10.1074/jbc.M411695200",
      "article-title": "Internalization and Src activity regulate the time course of ERK activation by delta opioid receptor ligands",
      "volume": "280",
      "author": "Audet",
      "year": "2005",
      "journal-title": "J. Biol. Chem."
    },
    {
      "key": "10.1016/j.tips.2007.06.005_bib34",
      "doi-asserted-by": "crossref",
      "first-page": "1603",
      "DOI": "10.1111/j.1471-4159.2005.03161.x",
      "article-title": "Characterization of serotonin 5-HT2C receptor signaling to extracellular signal-regulated kinases 1 and 2",
      "volume": "93",
      "author": "Werry",
      "year": "2005",
      "journal-title": "J. Neurochem."
    },
    {
      "key": "10.1016/j.tips.2007.06.005_bib35",
      "doi-asserted-by": "crossref",
      "first-page": "1575",
      "DOI": "10.1124/mol.106.026716",
      "article-title": "Distinct signaling profiles of beta1 and beta2 adrenergic receptor ligands toward adenylyl cyclase and mitogen-activated protein kinase reveals the pluridimensionality of efficacy",
      "volume": "70",
      "author": "Galandrin",
      "year": "2006",
      "journal-title": "Mol. Pharmacol."
    },
    {
      "key": "10.1016/j.tips.2007.06.005_bib36",
      "doi-asserted-by": "crossref",
      "first-page": "28268",
      "DOI": "10.1074/jbc.270.47.28268",
      "article-title": "Fluorescent labeling of purified beta 2 adrenergic receptor. Evidence for ligand-specific conformational changes",
      "volume": "270",
      "author": "Gether",
      "year": "1995",
      "journal-title": "J. Biol. Chem."
    },
    {
      "key": "10.1016/j.tips.2007.06.005_bib37",
      "doi-asserted-by": "crossref",
      "first-page": "24433",
      "DOI": "10.1074/jbc.C100162200",
      "article-title": "Functionally different agonists induce distinct conformations in the G protein coupling domain of the beta 2 adrenergic receptor",
      "volume": "276",
      "author": "Ghanouni",
      "year": "2001",
      "journal-title": "J. Biol. Chem."
    },
    {
      "key": "10.1016/j.tips.2007.06.005_bib38",
      "doi-asserted-by": "crossref",
      "first-page": "25",
      "DOI": "10.1038/nchembio705",
      "article-title": "Molecular basis of inverse agonism in a G protein-coupled receptor",
      "volume": "1",
      "author": "Vilardaga",
      "year": "2005",
      "journal-title": "Nat. Chem. Biol."
    },
    {
      "key": "10.1016/j.tips.2007.06.005_bib39",
      "doi-asserted-by": "crossref",
      "first-page": "171",
      "DOI": "10.1038/nmeth742",
      "article-title": "A FlAsH-based FRET approach to determine G protein-coupled receptor activation in living cells",
      "volume": "2",
      "author": "Hoffmann",
      "year": "2005",
      "journal-title": "Nat. Methods"
    },
    {
      "key": "10.1016/j.tips.2007.06.005_bib40",
      "doi-asserted-by": "crossref",
      "first-page": "177",
      "DOI": "10.1038/nmeth743",
      "article-title": "Real-time monitoring of receptor and G-protein interactions in living cells",
      "volume": "2",
      "author": "Gales",
      "year": "2005",
      "journal-title": "Nat. Methods"
    },
    {
      "key": "10.1016/j.tips.2007.06.005_bib41",
      "doi-asserted-by": "crossref",
      "first-page": "778",
      "DOI": "10.1038/nsmb1134",
      "article-title": "Probing the activation-promoted structural rearrangements in preassembled receptor-G protein complexes",
      "volume": "13",
      "author": "Gales",
      "year": "2006",
      "journal-title": "Nat. Struct. Mol. Biol."
    },
    {
      "key": "10.1016/j.tips.2007.06.005_bib42",
      "doi-asserted-by": "crossref",
      "first-page": "71",
      "DOI": "10.1042/0264-6021:3420071",
      "article-title": "Differential G-protein activation by alkaloid and peptide opioid agonists in the human neuroblastoma cell line SK-N-BE",
      "volume": "342",
      "author": "Allouche",
      "year": "1999",
      "journal-title": "Biochem. J."
    },
    {
      "key": "10.1016/j.tips.2007.06.005_bib43",
      "doi-asserted-by": "crossref",
      "first-page": "2016",
      "DOI": "10.1124/mol.104.003558",
      "article-title": "Chemically distinct ligands promote differential CB1 cannabinoid receptor-Gi protein interactions",
      "volume": "67",
      "author": "Mukhopadhyay",
      "year": "2005",
      "journal-title": "Mol. Pharmacol."
    },
    {
      "key": "10.1016/j.tips.2007.06.005_bib44",
      "doi-asserted-by": "crossref",
      "first-page": "578",
      "DOI": "10.1124/mol.62.3.578",
      "article-title": "Differential activation of Gq/11 and Gi(3) proteins at 5-hydroxytryptamine(2C) receptors revealed by antibody capture assays: influence of receptor reserve and relationship to agonist-directed trafficking",
      "volume": "62",
      "author": "Cussac",
      "year": "2002",
      "journal-title": "Mol. Pharmacol."
    },
    {
      "key": "10.1016/j.tips.2007.06.005_bib45",
      "first-page": "775",
      "article-title": "Functional coupling of the human dopamine D2 receptor with G alpha i1, G alpha i2",
      "volume": "138",
      "author": "Gazi",
      "year": "2003",
      "journal-title": "G alpha i3 and G alpha o G proteins: evidence for agonist regulation of G protein selectivity. Br. J. Pharmacol."
    },
    {
      "key": "10.1016/j.tips.2007.06.005_bib46",
      "doi-asserted-by": "crossref",
      "first-page": "1190",
      "DOI": "10.1046/j.1471-4159.2000.0751190.x",
      "article-title": "Coupling efficacy and selectivity of the human mu-opioid receptor expressed as receptor-Galpha fusion proteins in Escherichia coli",
      "volume": "75",
      "author": "Stanasila",
      "year": "2000",
      "journal-title": "J. Neurochem."
    },
    {
      "key": "10.1016/j.tips.2007.06.005_bib47",
      "doi-asserted-by": "crossref",
      "first-page": "858",
      "DOI": "10.1124/jpet.105.096818",
      "article-title": "Comparison of the relative efficacy and potency of mu-opioid agonists to activate Galpha(i/o) proteins containing a pertussis toxin-insensitive mutation",
      "volume": "317",
      "author": "Clark",
      "year": "2006",
      "journal-title": "J. Pharmacol. Exp. Ther."
    },
    {
      "key": "10.1016/j.tips.2007.06.005_bib48",
      "doi-asserted-by": "crossref",
      "first-page": "19144",
      "DOI": "10.1073/pnas.0509588102",
      "article-title": "The cannabinoid agonist WIN55,212-2 increases intracellular calcium via CB1 receptor coupling to Gq/11 G proteins",
      "volume": "102",
      "author": "Lauckner",
      "year": "2005",
      "journal-title": "Proc. Natl. Acad. Sci. U. S. A."
    },
    {
      "key": "10.1016/j.tips.2007.06.005_bib49",
      "doi-asserted-by": "crossref",
      "first-page": "28667",
      "DOI": "10.1074/jbc.M008644200",
      "article-title": "Agonist regulation of D(2) dopamine receptor/G protein interaction. Evidence for agonist selection of G protein subtype",
      "volume": "276",
      "author": "Cordeaux",
      "year": "2001",
      "journal-title": "J. Biol. Chem."
    },
    {
      "key": "10.1016/j.tips.2007.06.005_bib50",
      "doi-asserted-by": "crossref",
      "first-page": "1230",
      "DOI": "10.1124/mol.58.6.1230",
      "article-title": "The use of stimulus-biased assay systems to detect agonist-specific receptor active states: implications for the trafficking of receptor stimulus by agonists",
      "volume": "58",
      "author": "Watson",
      "year": "2000",
      "journal-title": "Mol. Pharmacol."
    },
    {
      "key": "10.1016/j.tips.2007.06.005_bib51",
      "doi-asserted-by": "crossref",
      "first-page": "28083",
      "DOI": "10.1074/jbc.M009772200",
      "article-title": "Bombesin and substance P analogues differentially regulate G-protein coupling to the bombesin receptor. Direct evidence for biased agonism",
      "volume": "276",
      "author": "MacKinnon",
      "year": "2001",
      "journal-title": "J. Biol. Chem."
    },
    {
      "key": "10.1016/j.tips.2007.06.005_bib52",
      "doi-asserted-by": "crossref",
      "first-page": "954",
      "DOI": "10.1124/mol.58.5.954",
      "article-title": "Molecular analysis of beta(2)-adrenoceptor coupling to G(s)-, G(i)-, and G(q)-proteins",
      "volume": "58",
      "author": "Wenzel-Seifert",
      "year": "2000",
      "journal-title": "Mol. Pharmacol."
    },
    {
      "key": "10.1016/j.tips.2007.06.005_bib53",
      "doi-asserted-by": "crossref",
      "first-page": "10782",
      "DOI": "10.1073/pnas.1834556100",
      "article-title": "Independent beta-arrestin 2 and G protein-mediated pathways for angiotensin II activation of extracellular signal-regulated kinases 1 and 2",
      "volume": "100",
      "author": "Wei",
      "year": "2003",
      "journal-title": "Proc. Natl. Acad. Sci. U. S. A."
    },
    {
      "key": "10.1016/j.tips.2007.06.005_bib54",
      "doi-asserted-by": "crossref",
      "first-page": "32",
      "DOI": "10.1016/j.cellsig.2006.05.020",
      "article-title": "The V2 vasopressin receptor stimulates ERK1/2 activity independently of heterotrimeric G protein signalling",
      "volume": "19",
      "author": "Charest",
      "year": "2007",
      "journal-title": "Cell. Signal."
    },
    {
      "key": "10.1016/j.tips.2007.06.005_bib55",
      "doi-asserted-by": "crossref",
      "first-page": "10856",
      "DOI": "10.1074/jbc.M513380200",
      "article-title": "Distinct beta-arrestin- and G protein-dependent pathways for parathyroid hormone receptor-stimulated ERK1/2 activation",
      "volume": "281",
      "author": "Gesty-Palmer",
      "year": "2006",
      "journal-title": "J. Biol. Chem."
    },
    {
      "key": "10.1016/j.tips.2007.06.005_bib56",
      "doi-asserted-by": "crossref",
      "first-page": "919",
      "DOI": "10.1038/nrd1875",
      "article-title": "New concepts in drug discovery: collateral efficacy and permissive antagonism",
      "volume": "4",
      "author": "Kenakin",
      "year": "2005",
      "journal-title": "Nat. Rev. Drug Discov."
    },
    {
      "key": "10.1016/j.tips.2007.06.005_bib57",
      "doi-asserted-by": "crossref",
      "first-page": "2893",
      "DOI": "10.1074/jbc.275.4.2893",
      "article-title": "Agonist-induced phosphorylation of the angiotensin II (AT(1A)) receptor requires generation of a conformation that is distinct from the inositol phosphate-signaling state",
      "volume": "275",
      "author": "Thomas",
      "year": "2000",
      "journal-title": "J. Biol. Chem."
    },
    {
      "key": "10.1016/j.tips.2007.06.005_bib58",
      "doi-asserted-by": "crossref",
      "first-page": "957",
      "DOI": "10.1124/jpet.302.3.957",
      "article-title": "Rapid desensitization of the serotonin(2C) receptor system: effector pathway and agonist dependence",
      "volume": "302",
      "author": "Stout",
      "year": "2002",
      "journal-title": "J. Pharmacol. Exp. Ther."
    },
    {
      "key": "10.1016/j.tips.2007.06.005_bib59",
      "doi-asserted-by": "crossref",
      "first-page": "782",
      "DOI": "10.1074/jbc.272.2.782",
      "article-title": "Differential opioid agonist regulation of the mouse mu opioid receptor",
      "volume": "272",
      "author": "Blake",
      "year": "1997",
      "journal-title": "J. Biol. Chem."
    },
    {
      "key": "10.1016/j.tips.2007.06.005_bib60",
      "doi-asserted-by": "crossref",
      "first-page": "231",
      "DOI": "10.1046/j.1471-4159.1998.71010231.x",
      "article-title": "Distinct differences between morphine- and [D-Ala2,N-MePhe4,Gly-ol5]-enkephalin-mu-opioid receptor complexes demonstrated by cyclic AMP-dependent protein kinase phosphorylation",
      "volume": "71",
      "author": "Chakrabarti",
      "year": "1998",
      "journal-title": "J. Neurochem."
    },
    {
      "key": "10.1016/j.tips.2007.06.005_bib61",
      "doi-asserted-by": "crossref",
      "first-page": "23214",
      "DOI": "10.1074/jbc.M402125200",
      "article-title": "Differential desensitization, receptor phosphorylation, beta-arrestin recruitment, and ERK1/2 activation by the two endogenous ligands for the CC chemokine receptor 7",
      "volume": "279",
      "author": "Kohout",
      "year": "2004",
      "journal-title": "J. Biol. Chem."
    },
    {
      "key": "10.1016/j.tips.2007.06.005_bib62",
      "doi-asserted-by": "crossref",
      "first-page": "24",
      "DOI": "10.1054/npep.2000.0840",
      "article-title": "The N-terminal domain of substance P is required for complete homologous desensitization but not phosphorylation of the rat neurokinin-1 receptor",
      "volume": "35",
      "author": "Vigna",
      "year": "2001",
      "journal-title": "Neuropeptides"
    },
    {
      "key": "10.1016/j.tips.2007.06.005_bib63",
      "doi-asserted-by": "crossref",
      "first-page": "9914",
      "DOI": "10.1073/pnas.95.17.9914",
      "article-title": "Morphine-activated opioid receptors elude desensitization by beta-arrestin",
      "volume": "95",
      "author": "Whistler",
      "year": "1998",
      "journal-title": "Proc. Natl. Acad. Sci. U. S. A."
    },
    {
      "key": "10.1016/j.tips.2007.06.005_bib64",
      "doi-asserted-by": "crossref",
      "first-page": "907",
      "DOI": "10.1124/jpet.106.109512",
      "article-title": "Functional selectivity of NK1 receptor signaling: peptide agonists can preferentially produce receptor activation or desensitization",
      "volume": "319",
      "author": "Simmons",
      "year": "2006",
      "journal-title": "J. Pharmacol. Exp. Ther."
    },
    {
      "key": "10.1016/j.tips.2007.06.005_bib65",
      "doi-asserted-by": "crossref",
      "first-page": "441",
      "DOI": "10.1016/S0361-9230(01)00623-2",
      "article-title": "Paradoxical trafficking and regulation of 5-HT(2A) receptors by agonists and antagonists",
      "volume": "56",
      "author": "Gray",
      "year": "2001",
      "journal-title": "Brain Res. Bull."
    },
    {
      "key": "10.1016/j.tips.2007.06.005_bib66",
      "doi-asserted-by": "crossref",
      "first-page": "357",
      "DOI": "10.1016/S0026-895X(24)13474-8",
      "article-title": "Antagonist-stimulated internalization of the G protein-coupled cholecystokinin receptor",
      "volume": "51",
      "author": "Roettger",
      "year": "1997",
      "journal-title": "Mol. Pharmacol."
    },
    {
      "key": "10.1016/j.tips.2007.06.005_bib67",
      "doi-asserted-by": "crossref",
      "first-page": "3185",
      "DOI": "10.1210/endo.139.7.6105",
      "article-title": "The endothelin subtype A receptor undergoes agonist- and antagonist-mediated internalization in the absence of signaling",
      "volume": "139",
      "author": "Bhowmick",
      "year": "1998",
      "journal-title": "Endocrinology"
    },
    {
      "key": "10.1016/j.tips.2007.06.005_bib68",
      "doi-asserted-by": "crossref",
      "first-page": "43787",
      "DOI": "10.1074/jbc.M306019200",
      "article-title": "Activation-independent parathyroid hormone receptor internalization is regulated by NHERF1 (EBP50)",
      "volume": "278",
      "author": "Sneddon",
      "year": "2003",
      "journal-title": "J. Biol. Chem."
    },
    {
      "key": "10.1016/j.tips.2007.06.005_bib69",
      "doi-asserted-by": "crossref",
      "first-page": "695",
      "DOI": "10.1038/sj.bjp.0705306",
      "article-title": "Agonist- and antagonist-induced sequestration/internalization of neuropeptide Y Y1 receptors in HEK293 cells",
      "volume": "139",
      "author": "Pheng",
      "year": "2003",
      "journal-title": "Br. J. Pharmacol."
    },
    {
      "key": "10.1016/j.tips.2007.06.005_bib70",
      "doi-asserted-by": "crossref",
      "first-page": "3037",
      "DOI": "10.4049/jimmunol.163.6.3037",
      "article-title": "Characterization of RANTES- and aminooxypentane-RANTES-triggered desensitization signals reveals differences in recruitment of the G protein-coupled receptor complex",
      "volume": "163",
      "author": "Vila-Coro",
      "year": "1999",
      "journal-title": "J. Immunol."
    },
    {
      "key": "10.1016/j.tips.2007.06.005_bib71",
      "doi-asserted-by": "crossref",
      "first-page": "1281",
      "DOI": "10.1124/jpet.105.083337",
      "article-title": "Functional selectivity of melanocortin 4 receptor peptide and nonpeptide agonists: evidence for ligand-specific conformational states",
      "volume": "313",
      "author": "Nickolls",
      "year": "2005",
      "journal-title": "J. Pharmacol. Exp. Ther."
    },
    {
      "key": "10.1016/j.tips.2007.06.005_bib72",
      "doi-asserted-by": "crossref",
      "first-page": "37447",
      "DOI": "10.1074/jbc.M605982200",
      "article-title": "The natural inverse agonist agouti-related protein induces arrestin-mediated endocytosis of melanocortin-3 and -4 receptors",
      "volume": "281",
      "author": "Breit",
      "year": "2006",
      "journal-title": "J. Biol. Chem."
    },
    {
      "key": "10.1016/j.tips.2007.06.005_bib73",
      "doi-asserted-by": "crossref",
      "first-page": "349",
      "DOI": "10.1146/annurev.pharmtox.42.091401.113012",
      "article-title": "Drug efficacy at G protein-coupled receptors",
      "volume": "42",
      "author": "Kenakin",
      "year": "2002",
      "journal-title": "Annu. Rev. Pharmacol. Toxicol."
    },
    {
      "key": "10.1016/j.tips.2007.06.005_bib74",
      "doi-asserted-by": "crossref",
      "first-page": "1532",
      "DOI": "10.1038/sj.onc.1204184",
      "article-title": "New mechanisms in heptahelical receptor signaling to mitogen activated protein kinase cascades",
      "volume": "20",
      "author": "Pierce",
      "year": "2001",
      "journal-title": "Oncogene"
    },
    {
      "key": "10.1016/j.tips.2007.06.005_bib75",
      "doi-asserted-by": "crossref",
      "first-page": "737",
      "DOI": "10.1016/S0896-6273(01)80032-5",
      "article-title": "Functional dissociation of mu opioid receptor signaling and endocytosis: implications for the biology of opiate tolerance and addiction",
      "volume": "23",
      "author": "Whistler",
      "year": "1999",
      "journal-title": "Neuron"
    },
    {
      "key": "10.1016/j.tips.2007.06.005_bib76",
      "doi-asserted-by": "crossref",
      "first-page": "1212",
      "DOI": "10.1124/jpet.105.090308",
      "article-title": "Allosteric potentiators of metabotropic glutamate receptor subtype 5 have differential effects on different signaling pathways in cortical astrocytes",
      "volume": "315",
      "author": "Zhang",
      "year": "2005",
      "journal-title": "J. Pharmacol. Exp. Ther."
    },
    {
      "key": "10.1016/j.tips.2007.06.005_bib77",
      "doi-asserted-by": "crossref",
      "first-page": "318",
      "DOI": "10.1002/cyto.a.20266",
      "article-title": "Multiplexed and microparticle-based analyses: quantitative tools for the large-scale analysis of biological systems",
      "volume": "69",
      "author": "Nolan",
      "year": "2006",
      "journal-title": "Cytometry A"
    },
    {
      "key": "10.1016/j.tips.2007.06.005_bib78",
      "doi-asserted-by": "crossref",
      "first-page": "663",
      "DOI": "10.1016/j.tips.2004.10.009",
      "article-title": "Techniques: GPCR assembly, pharmacology and screening by flow cytometry",
      "volume": "25",
      "author": "Waller",
      "year": "2004",
      "journal-title": "Trends Pharmacol. Sci."
    },
    {
      "key": "10.1016/j.tips.2007.06.005_bib79",
      "doi-asserted-by": "crossref",
      "first-page": "431",
      "DOI": "10.1089/adt.2004.2.431",
      "article-title": "Rapid structure-activity and selectivity analysis of kinase inhibitors by BioMAP analysis in complex human primary cell-based models",
      "volume": "2",
      "author": "Kunkel",
      "year": "2004",
      "journal-title": "Assay Drug Dev. Technol."
    },
    {
      "key": "10.1016/j.tips.2007.06.005_bib80",
      "doi-asserted-by": "crossref",
      "first-page": "1279",
      "DOI": "10.1096/fj.04-1538fje",
      "article-title": "An integrative biology approach for analysis of drug action in models of human vascular inflammation",
      "volume": "18",
      "author": "Kunkel",
      "year": "2004",
      "journal-title": "FASEB J."
    },
    {
      "key": "10.1016/j.tips.2007.06.005_bib81",
      "doi-asserted-by": "crossref",
      "first-page": "170",
      "DOI": "10.1016/S0076-6879(02)43134-5",
      "article-title": "Use of fluorescence spectroscopy to study conformational changes in the beta 2-adrenoceptor",
      "volume": "343",
      "author": "Kobilka",
      "year": "2002",
      "journal-title": "Methods Enzymol."
    }
  ],
  "container-title": "Trends in Pharmacological Sciences",
  "original-title": [],
  "language": "en",
  "link": [
    {
      "URL": "https://api.elsevier.com/content/article/PII:S0165614707001502?httpAccept=text/xml",
      "content-type": "text/xml",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://api.elsevier.com/content/article/PII:S0165614707001502?httpAccept=text/plain",
      "content-type": "text/plain",
      "content-version": "vor",
      "intended-application": "text-mining"
    }
  ],
  "deposited": {
    "date-parts": [
      [
        2025,
        1,
        19
      ]
    ],
    "date-time": "2025-01-19T20:18:24Z",
    "timestamp": 1737317904000
  },
  "score": 1,
  "resource": {
    "primary": {
      "URL": "https://linkinghub.elsevier.com/retrieve/pii/S0165614707001502"
    }
  },
  "subtitle": [],
  "short-title": [],
  "issued": {
    "date-parts": [
      [
        2007,
        8
      ]
    ]
  },
  "references-count": 81,
  "journal-issue": {
    "issue": "8",
    "published-print": {
      "date-parts": [
        [
          2007,
          8
        ]
      ]
    }
  },
  "alternative-id": [
    "S0165614707001502"
  ],
  "URL": "http://dx.doi.org/10.1016/j.tips.2007.06.005",
  "relation": {},
  "ISSN": [
    "0165-6147"
  ],
  "subject": [],
  "container-title-short": "Trends in Pharmacological Sciences",
  "published": {
    "date-parts": [
      [
        2007,
        8
      ]
    ]
  }
}